Search research articles
Contact Us
Filters
Showing results (61-70 of 98) with videos related to
Page
of 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2012
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
Chiara Laezza, Alba D'Alessandro, Simona Paladino, et al.
Oncology
|
February 17, 2005
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis
Maria Notarnicola, Caterina Messa, Aldo Cavallini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 27, 2006
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 2, 2013
Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives
Anna Maria Malfitano, Chiara Laezza, Giuseppe Saccomanni, et al.
Endocrine-Related Cancer
|
March 23, 2010
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
Chiara Laezza, Anna Maria Malfitano, Maria Chiara Proto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 23, 2013
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
Simona Pisanti, Paola Picardi, Elena Ciaglia, et al.
Plos One
|
May 10, 2013
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis
Anna Maria Malfitano, Chiara Laezza, Alba D'Alessandro, et al.
Cancers
|
October 2, 2019
N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor
Donatella Fiore, Chiara Piscopo, Maria Chiara Proto, et al.
Biomedicines
|
February 2, 2021
PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress
Vanessa Castelli, Mariano Catanesi, Margherita Alfonsetti, et al.
Cell Death Discovery
|
April 8, 2022
N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 98) with videos related to
Sort By:
Page
of 10
European Journal of Cancer (Oxford, England : 1990)
|
March 20, 2012
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells
Chiara Laezza, Alba D'Alessandro, Simona Paladino, et al.
Oncology
|
February 17, 2005
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis
Maria Notarnicola, Caterina Messa, Aldo Cavallini, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 27, 2006
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma
Alessia Ligresti, Aniello Schiano Moriello, Katarzyna Starowicz, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology
|
October 2, 2013
Immune-modulation and properties of absorption and blood brain barrier permeability of 1,8-naphthyridine derivatives
Anna Maria Malfitano, Chiara Laezza, Giuseppe Saccomanni, et al.
Endocrine-Related Cancer
|
March 23, 2010
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells
Chiara Laezza, Anna Maria Malfitano, Maria Chiara Proto, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
November 23, 2013
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation
Simona Pisanti, Paola Picardi, Elena Ciaglia, et al.
Plos One
|
May 10, 2013
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis
Anna Maria Malfitano, Chiara Laezza, Alba D'Alessandro, et al.
Cancers
|
October 2, 2019
N6-Isopentenyladenosine Inhibits Colorectal Cancer and Improves Sensitivity to 5-Fluorouracil-Targeting FBXW7 Tumor Suppressor
Donatella Fiore, Chiara Piscopo, Maria Chiara Proto, et al.
Biomedicines
|
February 2, 2021
PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress
Vanessa Castelli, Mariano Catanesi, Margherita Alfonsetti, et al.
Cell Death Discovery
|
April 8, 2022
N6-isopentenyladenosine induces cell death through necroptosis in human glioblastoma cells
Cristina Pagano, Giovanna Navarra, Laura Coppola, et al.
Page
of 10